Satellos Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9.8	40.07	16.65	1.42	3.85
Short-Term Investments	17.91	8.48	13.22	-	-
Cash & Short-Term Investments	27.71	48.55	29.88	1.42	3.85
Cash Growth	-42.92%	62.49%	2007.15%	-63.21%	583.78%
Accounts Receivable	-	-	-	-	0
Other Receivables	0.37	0.44	0.44	0.19	0.42
Total Trade Receivables	0.37	0.44	0.44	0.19	0.42
Other Current Assets	3.8	1.76	0.11	0.04	0.03
Total Current Assets	31.88	50.74	30.43	1.65	4.31
Net Property, Plant & Equipment	0.01	0	0.01	0.01	0.01
Other Intangible Assets	-	-	2.96	2.89	5.65
Long-Term Investments	-	-	0.03	0.03	-
Other Long-Term Assets	-	-	-	-	5.65
Total Assets	31.89	50.75	33.43	4.57	9.96
Accounts Payable	4.11	3.58	2.74	2.09	1.66
Accrued Expenses	4.11	3.58	2.74	2.09	1.66
Total Current Liabilities	4.11	3.58	2.74	2.09	1.66
Total Liabilities	4.11	3.58	2.74	2.09	1.66
Common Stock	85.83	78.13	46.73	22.26	22.4
Additional Paid-in Capital	25.65	27.87	19.83	3.52	1.95
Accumulated Other Comprehensive Income	-1.72	-1.74	-0.01	-0.01	-0
Retained Earnings	-81.97	-57.1	-35.85	-23.3	-16.05
Shareholders' Equity	27.78	47.16	30.7	2.48	8.29
Total Liabilities & Equity	31.89	50.75	33.43	4.57	9.96
Net Cash (Debt)	27.71	48.55	29.88	1.42	3.85
Net Cash Growth	-42.92%	62.49%	2007.15%	-63.21%	-
Net Cash Per Share	1.90	5.08	4.15	0.48	1.92
Book Value	27.78	47.16	30.7	2.48	8.29
Book Value Per Share	1.90	4.93	4.26	0.84	4.13
Tangible Book Value	27.78	47.16	27.74	-0.4	2.65
Tangible Book Value Per Share	1.90	4.93	3.85	-0.14	1.32

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.